<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F
Form 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: SEPTEMBER 30, 2000
Check here if Amendment / /; Amendment Number:
This Amendment [Check only one.]: / / is a restatement
/ / adds new holdings entries
Institutional Investment Manager Filing this Report:
Name: BVF INC.
Address: 227 WEST MONROE STREET, SUITE 4800
CHICAGO, ILLINOIS 60606
Form 13F File Number: 28-6800
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form. Person
Signing this Report on Behalf of Reporting Manager:
Name: MARK N. LAMPERT
Title: PRESIDENT
Phone: (312) 263-7777
Signature, Place and Date of Signing:
/s/ MARK N. LAMPERT SAN FRANCISCO, CALIFORNIA 11/14/00
---------------------------------------------------------------------
[Signature] [City, State] [Date]
Report Type (Check only one):
/X/ 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager
are reported in this report.)
/ / 13F NOTICE. (Check here if no holdings reported are in this report,
and all holdings are reported by other reporting manager(s)).
<PAGE>
/ / 13F COMBINATION REPORT. (Check here if a portion of the holdings for
this reporting manager are reported in this report and a portion are
reported by other reporting manager(s).)
Report Summary:
Number of Other Included Managers: 1
--------------------------
Form 13F Information Table Entry Total: 15
--------------------------
Form 13F Information Table Value Total: $238,753
--------------------------
(thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
[If there are no entries in this list, state "NONE" and omit the column headings
and list entries.]
No. Form 13F File Number Name
1. 28-6770 BVF PARTNERS L.P.
<PAGE>
Page 3 of 1
FORM 13F
Name of Reporting Manager: BVF Inc.
<TABLE>
<CAPTION>
---------------------------------- ------------- -------------- ------------ -------------------------------- -------------
Column 1: Column 2: Column 3: Column 4: Column 5: Column 6:
Name of Issuer Title of CUSIP Value Investment
Class (x$1000) Discretion
---------------------------------- ------------- -------------- ------------ -------------------------------- -------------
Shrs Sh/ Put/
Prn Prn Call
---------------------------------- ------------- -------------- ------------ ------------ --------- --------- -------------
<S> <C> <C> <C> <C> <C> <C> <C>
---------------------------------- ------------- -------------- ------------ ------------ --------- --------- -------------
Access Pharmaceuticals Inc. Com New 00431M209 448 64,600 Sh Defined
---------------------------------- ------------- -------------- ------------ ------------ --------- --------- -------------
Advanced Magnetics Inc. Com 00753P103 2,280 608,133 Sh Defined
---------------------------------- ------------- -------------- ------------ ------------ --------- --------- -------------
American Biogenetic Sciences, Inc. CL A 024611105 9,375 6,000,000 Sh Defined
---------------------------------- ------------- -------------- ------------ ------------ --------- --------- -------------
Autoimmune Inc. Com 052776101 7,143 2,893,078 Sh Defined
---------------------------------- ------------- -------------- ------------ ------------ --------- --------- -------------
Biocryst Pharmaceuticals Com 09058V103 17,100 821,600 Sh Defined
---------------------------------- ------------- -------------- ------------ ------------ --------- --------- -------------
Caliper Technologies Corp. Com 130876105 1,159 20,000 Sh Defined
---------------------------------- ------------- -------------- ------------ ------------ --------- --------- -------------
Cortech Inc. Com New 22051J308 2,713 355,783 Sh Defined
---------------------------------- ------------- -------------- ------------ ------------ --------- --------- -------------
Corvas Int'l Inc. Com 221005101 66,975 2,880,651 Sh Defined
---------------------------------- ------------- -------------- ------------ ------------ --------- --------- -------------
Epimmune Inc. Com 29425Y101 2,138 475,100 Sh Defined
---------------------------------- ------------- -------------- ------------ ------------ --------- --------- -------------
Flamel Technologies S.A Sponsored 338488109 8,906 1,250,000 Sh Defined
ADR
---------------------------------- ------------- -------------- ------------ ------------ --------- --------- -------------
Microcide Pharmaceutcls. Inc. Com 595018102 13,163 975,007 Sh Defined
---------------------------------- ------------- -------------- ------------ ------------ --------- --------- -------------
Neurogen Corp. Com 64124E106 10,011 321,649 Sh Defined
---------------------------------- ------------- -------------- ------------ ------------ --------- --------- -------------
OSI Pharmaceuticals Inc. Com 671040103 86,486 1,235,519 Sh Defined
---------------------------------- ------------- -------------- ------------ ------------ --------- --------- -------------
Synaptic Pharmaceutical Corp. Com 87156R109 7,845 1,110,783 Sh Defined
---------------------------------- ------------- -------------- ------------ ------------ --------- --------- -------------
Elan PLC ADR 284131208 3,011 55,000 Sh Put Defined
---------------------------------- ------------- -------------- ------------ ------------ --------- --------- -------------
TOTAL 238,753
---------------------------------- ------------- -------------- ------------ ------------ --------- --------- -------------
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
---------------------------
(SEC USE ONLY)
---------------------------------- -------------- ------------------------------------------
Column 1: Column 7: Column 8:
Name of Issuer Other Voting Authority
Managers
---------------------------------- -------------- ------------------------------------------
---------------------------------- -------------- -------------- --------------- -----------
Sole Shared None
---------------------------------- -------------- -------------- --------------- -----------
---------------------------------- -------------- -------------- --------------- -----------
---------------------------------- -------------- -------------- --------------- -----------
<S> <C> <C> <C> <C>
Access Pharmaceuticals, Inc. 1 64,600
---------------------------------- -------------- -------------- --------------- -----------
---------------------------------- -------------- -------------- --------------- -----------
Advanced Magnetics Inc. 1 608,133
---------------------------------- -------------- -------------- --------------- -----------
---------------------------------- -------------- -------------- --------------- -----------
American Biogenetics 1 6,000,000
---------------------------------- -------------- -------------- --------------- -----------
---------------------------------- -------------- -------------- --------------- -----------
Autoimmune Inc. 1 2,893,078
---------------------------------- -------------- -------------- --------------- -----------
---------------------------------- -------------- -------------- --------------- -----------
Biocryst Pharmaceuticals, Inc. 1 821,600
---------------------------------- -------------- -------------- --------------- -----------
---------------------------------- -------------- -------------- --------------- -----------
Caliper Tech 1 20,000
---------------------------------- -------------- -------------- --------------- -----------
---------------------------------- -------------- -------------- --------------- -----------
Cortech Inc. 1 355,783
---------------------------------- -------------- -------------- --------------- -----------
---------------------------------- -------------- -------------- --------------- -----------
Corvas Int'l Inc. 1 2,880,651
---------------------------------- -------------- -------------- --------------- -----------
---------------------------------- -------------- -------------- --------------- -----------
Epimmune Inc. 1 475,100
---------------------------------- -------------- -------------- --------------- -----------
---------------------------------- -------------- -------------- --------------- -----------
Flamel Technologies S.A 1 1,250,000
---------------------------------- -------------- -------------- --------------- -----------
---------------------------------- -------------- -------------- --------------- -----------
Microcide Pharmaceutcls. Inc. 1 975,007
---------------------------------- -------------- -------------- --------------- -----------
---------------------------------- -------------- -------------- --------------- -----------
Neurogen Corp. 1 321,649
---------------------------------- -------------- -------------- --------------- -----------
---------------------------------- -------------- -------------- --------------- -----------
OSI Pharmaceuticals Inc. 1 1,235,519
---------------------------------- -------------- -------------- --------------- -----------
---------------------------------- -------------- -------------- --------------- -----------
Synaptic Pharmaceutical Corp. 1 1,110,783
---------------------------------- -------------- -------------- --------------- -----------
---------------------------------- -------------- -------------- --------------- -----------
Elan PLC 1 55,000
---------------------------------- -------------- -------------- --------------- -----------
---------------------------------- -------------- -------------- --------------- -----------
---------------------------------- -------------- -------------- --------------- -----------
</TABLE>
